Affiliation:
1. School of Pharmaceutical Sciences, Lovely Professional University, Punjab-144411, India
Abstract
Background:
Chrysin, a flavonoid, occurs naturally in plants and possesses many pharmacological
actions, but there is a lack of suitable analytical methods for its estimation.
Objective:
To develop a simple analytical method and validate it for the estimation of chrysin using
reverse phase high-performance liquid chromatography (RP-HPLC).
Methods:
Isocratic elution was carried out in methanol and 0.1% v/v formic acid in a 70:30 ratio using a
C-18 reverse-phase column. The flow rate was set to 1 mL min-1 and the detection wavelength at 268 nm.
As per ICH Q2 (R1) guidelines, the developed method was validated in terms of accuracy, precision,
system suitability, and robustness.
Results:
The retention time of Chrysin was found at 10.269 min. In the concentration range of 2-10
μg/mL, the developed method was linear with a regression coefficient (R2) value of 0.998. The mean
percentage recovery of chrysin was found within 95-105% at all three levels, which confirms that the
developed method was accurate. Moreover, the % RSD was found to be less than 2% confirming that the
developed method was precise. The limit of detection and limit of quantification were found to be 0.071
and 0.217 μg/mL. Moreover, the validated method was robust with no significant changes in response to
variation in flow rate, mobile phase composition, wavelength, and different lots of columns.
Conclusion:
It was concluded that the developed method has passed all validation tests and was successfully
applied to estimate the presence of Chrysin in bulk as well as in pharmaceutical formulations.
Publisher
Bentham Science Publishers Ltd.
Subject
General Engineering,General Materials Science
Reference22 articles.
1. Naz S.; Imran M.; Rauf A.; Orhan I.E.; Shariati M.A.; Iahtisham-Ul-Haq; IqraYasmin; Shahbaz, M.; Qaisrani, T.B.; Shah, Z.A.; Plygun, S.; Heydari, M. Chrysin: Pharmacological and therapeutic properties. Life Sci 2019,235,116797
2. Stompor-Gorący, M.; Bajek-Bil, A.; Machaczka, M. Chrysin: Perspectives on contemporary status and future possibilities as pro-health agent. Nutrients 2021,13(6),2038
3. Mani R.; Natesan V.; Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry 2018,145,187-196
4. Siddiqui A.; Akhtar J.; Uddin M.S.; Khan M.I.; Khalid M.; Ahmad M.; A naturally occurring of flavone (Chrysin): Chemistry, occurrence, pharmacokinetic, toxicity, molecular targets and medicinal properties. J Biol Act Prod Nat 2018,8(4),208-227
5. Talebi M.; Talebi M.; Farkhondeh T.; Simal-Gandara J.; Kopustinskiene D.M.; Bernatoniene J.; Samarghandian S.; Emerging cellular and molecular mechanisms underlying anticancer indications of Chrysin. Cancer Cell Int 2021,21(1),214